4/A

OWNERSHIP DOCUMENT

Company: BioXcel Therapeutics, Inc.
Filed: September 17, 2024
Period of Report: June 15, 2024
Accession Number: 0001104659-24-100745

View Document ↗ View on SEC.gov ↗